Skip to main content
Ingredients/Vitamin/Benfotiamine

Benfotiamine.

Fat-soluble B1. Better for nerves than regular thiamine. Fat-soluble B1 that gets absorbed 5x better than regular thiamine. Protects nerves and helps metabolize glucose.

Extensively studiedResearch depth150 to 300mgDaily amount909Studies read

Reviewed March 2026

BEVitamin
BenfotiamineIngredientMD
Category
Vitamin

Also filed under
NervesNeuropathyGlucose metabolism

What Benfotiamine is, and what it does.

Does it work
Yes, especially for metabolic or nerve issues. If you need B1, this is the form to use.
How much to take
150-300mg daily. Can go higher for therapeutic purposes. Much more effective than high-dose regular B1.
Time to feel it
Blood thiamine rises within hours of the first dose. Anything you would notice builds over weeks, and status is read on a thiamine or red cell transketolase panel.
The first dose
Blood thiamine climbs within hours of the first capsule. Nothing in your day changes yet, and what has moved is a lab value feeding the enzymes that run carbohydrate metabolism.
With regular use
Improved nerve function, protection against glycation, better glucose metabolism.
How well tolerated
Well tolerated. Water-soluble vitamins have wide safety margins. This is just a better-absorbed version.
How it feels
Those with neuropathy often notice reduced symptoms. Otherwise subtle.
The overlooked benefit
Thiamine only becomes active after a magnesium and ATP dependent phosphorylation step, so your magnesium status quietly sets the ceiling on what any B1 form can do.

150 to 300mg a day is where Benfotiamine works.

How much to take a dayMedium confidence
Up to 150mgA supporting role. Common in blends where this is one active among several.
150 to 300mg
Daily maintenanceThe everyday amount, and where most daily supplements sit. This is the one you take month after month.
600mgClinical territory. Trials run high on purpose, for a set number of weeks, against one measured outcome. Impressive to hit, and not what a daily product is for.
Above 900mgPast what the research covers. More capsules rather than more effect.
MORE EFFECT ↑0300mg600mg plateauDAILY DOSE →
The shaded band is where the dosing trials landed.

Source: Stracke et al. (2008) Diabetes Care; Haupt et al. (2005) Int J Clin Pharmacol Ther

The proof, claim by claim.

These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.

Extensively studied.

Based on 25 human trials with 70% consistency.

  • Raising blood and tissue thiamine levelsRandomised trial
  • Red blood cell transketolase activityRandomised trial
  • Nerve comfort in the hands and feetRandomised trial
  • Advanced glycation end product formationRandomised trial
  • Markers of normal glucose handlingRandomised trial
PubMedCochraneClinicalTrials.govNIH ODSSUPP.AI909 studies readLabs test. IngredientMD verifies.PubMedCochraneClinicalTrials.govNIH ODSSUPP.AI909 studies readLabs test. IngredientMD verifies.

Questions people ask about Benfotiamine.

When should I take it?
Timing matters less than consistency. Pick a time that works for you and take it daily.
Can I take it with other supplements?
Usually fine. The main thing to watch is not doubling up on the same ingredient from different products. If you're on prescription meds, check with your pharmacist first.
Any side effects to watch for?
Most people tolerate it well at recommended doses. GI upset is the most common complaint with any supplement. Start with a lower dose and work up. If something feels off, stop and reassess.
Pairs well with18 on file

Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.

Benfotiamine + Thiamine HCL (Vitamin B1)same vitamin, different absorption route

Benfotiamine is a lipid-soluble thiamine prodrug that is dephosphorylated to S-benzoylthiamine and bypasses the saturable intestinal thiamine transporter that limits water-soluble thiamine at higher doses. Stacking the two overlaps on one vitamin rather than adding a second nutrient.

Benfotiamine + Magnesiummagnesium is required to activate and use thiamine

Thiamine pyrophosphokinase needs magnesium to convert thiamine into thiamine diphosphate, and the diphosphate-dependent enzymes bind magnesium at their active sites. Without adequate magnesium a thiamine dose is poorly converted into the working cofactor.

Benfotiamine + Alpha Lipoic Acidtwo cofactors of the same dehydrogenase complexes

Pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase each need thiamine diphosphate and a lipoamide arm to move the substrate through the complex. The pairing rests on that shared enzyme architecture.

Benfotiamine + Vitamin B2 (Riboflavin)a third cofactor of the same complexes

The same dehydrogenase complexes that use thiamine diphosphate also require FAD, which comes from riboflavin, to reoxidise the lipoamide arm. A shortfall in either cofactor stalls the whole complex.

Benfotiamine + Vitamin B3 (Niacin)NAD is the terminal acceptor of the same complexes

Pyruvate and alpha-ketoglutarate dehydrogenase pass electrons to NAD, which niacin supplies, after the thiamine diphosphate step has done its work. Both vitamins are needed for one continuous reaction.

Benfotiamine + Vitamin B5 (Pantothenic Acid)coenzyme A accepts the product of the thiamine step

Pantothenic acid builds coenzyme A, which accepts the acyl group that the thiamine diphosphate step generates in these complexes. The five-cofactor set is textbook and incomplete if any member is missing.

Benfotiamine + Vitamin B12separate requirements of nerve tissue

Cobalamin supports the methylation chemistry behind myelin upkeep while thiamine diphosphate supports the carbohydrate oxidation a nerve cell runs on. B1, B6 and B12 have been formulated together for nerve support on that split.

Benfotiamine + Vitamin B6 (Pyridoxine)separate requirements of nerve tissue

Pyridoxal phosphate runs the transamination and neurotransmitter steps of nerve metabolism while thiamine diphosphate runs the carbohydrate oxidation side. Nerve formulas keep B6 moderate, since high intakes carry their own upper limit.

Benfotiamine + Acetyl-L-Carnitine (ALCAR)complementary mitochondrial fuel handling

Carnitine carries fatty acids into the mitochondrion while thiamine diphosphate gates entry of glucose-derived pyruvate into the same cycle. The pair covers both fuel routes.

Benfotiamine + Biotinneighbouring steps in carbohydrate handling

Biotin-dependent pyruvate carboxylase and thiamine-dependent pyruvate dehydrogenase draw on the same pyruvate pool and route it either to oxidation or to replenishing the cycle. Covering both keeps that branch point supplied.

Benfotiamine + Coenzyme Q10consecutive stages of mitochondrial energy handling

Thiamine diphosphate enzymes feed reducing equivalents into the respiratory chain, where coenzyme Q10 carries electrons onward. Each addresses a different stage of the same pathway.

Benfotiamine + ThiamineBoth deliver thiamine to the same body pool by different absorption routes

Water-soluble thiamine salts depend on the saturable ThTr1 and ThTr2 transporters in the intestine, which caps how much a single large dose can deliver. Benfotiamine is dephosphorylated at the brush border and crosses less dependently on that transporter. Taken together they contribute to one thiamine total rather than two separate ones.

Benfotiamine + GlutathioneTransketolase directs substrate into the pentose phosphate pathway, the main source of NADPH for glutathione reduction

Thiamine diphosphate is the cofactor for transketolase, and transketolase activity is what routes sugar phosphates through the non-oxidative pentose phosphate pathway. The oxidative arm of that same pathway generates NADPH, which glutathione reductase uses to return oxidised glutathione to its active form. The link is biochemical and does not require a combination trial.

Benfotiamine + NACCysteine supply for glutathione synthesis, downstream of the same NADPH economy

NAC supplies the rate-limiting cysteine for glutathione synthesis while thiamine-dependent transketolase feeds the NADPH that keeps that glutathione reduced. One provides the material, the other supports the recycling. Both parts are established individually; the pairing has not been measured as such.

Benfotiamine + L-carnitineBoth act at mitochondrial substrate entry, on different fuels

Thiamine diphosphate is required by pyruvate dehydrogenase for glucose-derived carbon to enter the citric acid cycle, while carnitine governs long-chain fatty acid entry. The two cover the two main fuel routes into the same mitochondrion. Presented as complementary biochemistry, not a tested combination.

Benfotiamine + MCT oilBenfotiamine is more lipophilic than thiamine salts because of its S-benzoyl group

The benzoyl substitution makes benfotiamine less water-loving than thiamine hydrochloride, which is part of why it disperses differently in the gut. A lipid carrier is used in some formats on that basis. The practical size of any absorption difference from the vehicle has not been quantified.

Benfotiamine + Activated charcoalNon-specific adsorption of small water-soluble molecules in the gut

Activated charcoal binds a wide range of small molecules indiscriminately, including vitamins, and does not distinguish a supplement from anything else in the lumen. Taken in the same window it can reduce how much benfotiamine is available for absorption. Separating them by several hours avoids the overlap.

Benfotiamine + BerberineBoth are used in formulas addressing normal glucose handling and both act on carbohydrate metabolism enzymes

Thiamine diphosphate dependent enzymes sit at key branch points of glucose oxidation, and berberine acts on cellular energy sensing that also affects glucose uptake. Combined, the direction of effect on blood glucose is additive rather than opposing. Anyone monitoring blood glucose should account for both being present.

Who should be cautious

Nothing specific on file for Benfotiamine. Match the label to the daily amount above, and tell your doctor what you take.

Not medical advice. Show the label to your pharmacist.

What Benfotiamine actually does.

Established

Benfotiamine is S-benzoylthiamine O-monophosphate, a synthetic thiamine derivative in which the thiazole ring is opened and carries a benzoyl group on the sulfur.

Established

It acts as a prodrug: intestinal alkaline phosphatase removes the phosphate at the brush border, giving S-benzoylthiamine, which is then debenzoylated to thiamine inside cells and in the bloodstream.

Established

Thiamine is phosphorylated to thiamine diphosphate, which is the required cofactor for pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, branched-chain ketoacid dehydrogenase and transketolase.

Established

Transketolase moves two-carbon units between sugar phosphates, connecting glycolysis to the pentose phosphate pathway, and its activity in red blood cells is the classical functional assay of thiamine status.

Made in a lab, 6 steps on record

Where Benfotiamine comes from.

Benfotiamine starts as ordinary vitamin B1. Chemists open one of its rings, attach a benzoyl group to the sulfur that this exposes, and add a phosphate, which turns it into a molecule the gut handles differently. Nothing is extracted from a plant, though similar sulfur-modified B1 compounds do turn up naturally in garlic and onions.

Chemically synthesised. The molecule is identical to the one a plant or an animal makes, and building it deliberately means a known purity, a fixed dose and no crop contaminants. For several nutrients this is the only route that reaches a usable amount.

Starts as
Thiamine (vitamin B1)

Synthetic thiamine, itself built from a pyrimidine and a thiazole fragment, is the starting material

Converted by
Ring opening under alkaline conditions

Base opens the thiazole ring of thiamine, exposing a free thiol group on the resulting open-chain thiol form

Converted by
S-benzoylation

Benzoyl chloride reacts with the exposed thiol to install the benzoyl group that defines the S-acyl thiamine class

Converted by
O-phosphorylation

A phosphate group is placed on the hydroxyethyl side chain, giving S-benzoylthiamine O-monophosphate

Purified by
Crystallisation and washing

The product is crystallised out and washed to remove reagent residues and reaction by-products

Ends up as
White crystalline powder

Dried and milled for encapsulation or tabletting, assayed by HPLC against a reference standard

Getting Benfotiamine from food.

The whole-food sources on file. A supplement closes the gap, it does not replace dinner.

Garlic (raw)Onions (raw)

A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.

The forms it comes in.

BenfotiamineOpen-ring thiamine derivative with a benzoyl group on sulfur and a phosphate on the hydroxyethyl side chainFits Capsules and tablets where higher blood thiamine from an oral dose is the objectiveTrade-off Delivers thiamine to blood and most tissues well, while brain uptake is not the same as with the lipid-soluble disulfide derivatives
Lipid-dispersed benfotiamineThe same molecule pre-dispersed in a triglyceride base rather than delivered as a dry powderFits Softgel formats and combination products already built around an oil phaseTrade-off Larger capsule volume for the same milligram dose and an added fat carrier that some formulas do not wantActive and formulation aid
Thiamine mononitrateA less hygroscopic thiamine salt widely used in tablets and fortified foodsFits Dry blends and tablets where moisture pickup would otherwise be a manufacturing problemTrade-off Same transporter-dependent absorption profile as the hydrochloride salt
SulbutiamineA lipid-soluble thiamine disulfide dimer, chemically distinct from the S-acyl class benfotiamine belongs toFits Formulas targeting nervous tissue, where the disulfide class crosses membranes differentlyTrade-off A different molecule with its own literature and its own regulatory standing by market, so it is not an equivalent swap for benfotiamine
What the strongest studies found

The essence, in one line each.

  1. A published protocol for a 12-month double-blind placebo-controlled trial of benfotiamine; it describes the planned design and endpoints and reports no results.Randomised trial. Bönhof GJ et al., 2022 (BMJ Open). PMID 35115359
  2. Change in psychiatric symptom scores after benfotiamine differed by lifetime severity of alcohol use and by sex, with the reported signal confined to males; a subgroup finding from a small trial.Randomised trial. Manzardo AM et al., 2015 (Drug and Alcohol Dependence). PMID 25908323
  3. Benfotiamine raised muscle thiamine content and shifted energy-metabolism enzyme measures in endurance-trained mice; a rodent tissue finding.Animal study. Gonçalves AC et al., 2024 (Journal of Nutrition and Metabolism). PMID 39364430
  4. Benfotiamine supplementation lowered oxidative stress markers in skeletal and cardiac muscle tissue in an exercise model; tissue markers in animals, not a human outcome.Animal study. Gonçalves AC et al., 2019 (Journal of Integrative Medicine). PMID 31395444
  5. A critical review of the mechanistic rationale for combining alpha-lipoic acid with benfotiamine in nerve function support; the authors report the mechanism is plausible while controlled human data for the combination remains limited.Narrative review. Ciubotaru A et al., 2026 (Nutrients). PMID 42196997
  6. Pooled trials of thiamine supplementation and blood glucose markers in adults with high blood sugar, with benfotiamine named among the forms used; glycaemic laboratory markers, and the pooled trials differ in form and dose.Meta-analysis. Muley A et al., 2022 (BMJ Open). PMID 36008064
  7. A placebo-controlled trial of a multi-ingredient product containing benfotiamine in healthy adults with everyday aches; because several actives were combined, the design cannot isolate benfotiamine's contribution.Randomised trial. Evans M et al., 2020 (Nutrients). PMID 32575480
  8. A published pilot trial protocol targeting glycation stress in postmenopausal women in which benfotiamine appears among the named interventions; protocol only, no results reported.Randomised trial. Tanwar V et al., 2026 (npj Aging). PMID 42026060
  9. A mechanistic review proposing thiamine as a modulator of the nuclear receptor PPAR gamma, drawing on modelling and preclinical work rather than human results.Narrative review. Panati K et al., 2025 (Frontiers in Pharmacology). PMID 41368574
  10. A comparison of thiamine with a lipid-modified thiamine derivative for uptake and activity in fruit flies; an invertebrate model that speaks to derivative chemistry, not to human dosing.Animal study. Nevermann S et al., 2026 (Frontiers in Nutrition). PMID 42421918
  11. A review of inflammatory markers in adults with high blood sugar and vascular complications that names benfotiamine among the interventions surveyed; descriptive, with no pooled effect estimate.Narrative review. Nwadiugwu MC et al., 2020 (Frontiers in Public Health). PMID 33569370

These are the studies our verdict leans on, chosen from the 11 we read for Benfotiamine. The full linked list is below.

Primary evidence

The studies, linked.

12 sources behind our Benfotiamine verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.

  1. ClinicalTrials.gov
  2. ClinicalTrials.gov
  3. Clinical trialBenfotiamine in Alzheimer's Disease: A Pilot Study
    PHASE2 · 71 participants · Completed
    ClinicalTrials.gov
  4. ClinicalTrials.gov
  5. ClinicalTrials.gov
  6. ClinicalTrials.gov
  7. Clinical trialBenfotiamine Prevents Vascular Dysfunction in Healthy Smokers
    PHASE3 · 20 participants · Completed
    ClinicalTrials.gov
  8. ClinicalTrials.gov
  9. ClinicalTrials.gov
  10. ClinicalTrials.gov
  11. ClinicalTrials.gov
  12. ClinicalTrials.gov

Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.

Side effects reported to the FDA

Problems people have reported.

Read this carefully. These are 5,656 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Benfotiamine is, not how risky it is. A report is not proof Benfotiamine caused anything. It is a signal of what to watch for, nothing more.

Off Label Use
142
Dyspnoea
137
Drug Ineffective
126
Fatigue
117
Pain
114
Nausea
101

Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.